Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy (Q42547059)

2 November 2017

Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy (English)

1 reference

2 November 2017

1 reference

1 reference

1 reference

Berger T

1

1 reference

2 November 2017

Malayeri R

2

1 reference

2 November 2017

Doppelbauer A

3

1 reference

2 November 2017

Krajnik G

4

1 reference

2 November 2017

Huber H

5

1 reference

2 November 2017

Auff E

6

1 reference

2 November 2017

Pirker R

7

1 reference

2 November 2017

1 August 1997

1 reference

European Journal of Cancer

2 November 2017

1 reference

2 November 2017

33

1 reference

2 November 2017

9

1 reference

2 November 2017

1393-1399

1 reference

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

2 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Taxol: a novel investigational antimicrotubule agent

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

1 reference

7 January 2021

Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Paclitaxel (Taxol) induces cumulative mild neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Taxol produces a predominantly sensory neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Peripheral sensory neuropathy and cisplatin chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Taxol neuropathy. Electrodiagnostic and sural nerve biopsy findings

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Peripheral neurotoxicity of taxol in patients previously treated with cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Nerve Growth Factor Attenuates Neurotoxic Effects of Taxol on Spinal Cord-Ganglion Explants from Fetal Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Nerve growth factor prevents experimental cisplatin neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Protection by an ACTH4-9 analogue against the toxic effects of cisplatin and taxol on sensory neurons and glial cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Growth factors: potential therapeutic applications in neurology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Vinorelbine after paclitaxel in breast cancer: cross resistance and cumulative neurotoxicity?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

Severe neurotoxicity from vinorelbine-paclitaxel combinations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900103-2

7 January 2021

10.1016/S0959-8049(97)00103-2

Identifiers

DOI

1 reference

2 November 2017

1 reference